Response to the Letter to the Editor: "Lazertinib in EGFR-Mutated NSCLC with CNS Metastases: Reinforcing the Role of Third-Generation TKIs through Pooled Analysis

Cho, Byoung Chul; Kim, YuKyung

doi:10.1016/j.clc.2025.11.013

1. Journal Papers
Dept. of Internal Medicine (내과학교실)
1. College of Medicine (의과대학)

0 20

Cited 0 times in

Response to the Letter to the Editor: "Lazertinib in EGFR-Mutated NSCLC with CNS Metastases: Reinforcing the Role of Third-Generation TKIs through Pooled Analysis

Authors: Cho, Byoung Chul ; Kim, YuKyung

Citation: CLINICAL LUNG CANCER, Vol.27(1) : 72-73, 2026-01

Journal Title: CLINICAL LUNG CANCER

ISSN: 1525-7304

Issue Date: 2026-01

Full Text: https://www.sciencedirect.com/science/article/pii/S1525730425003213

DOI: 10.1016/j.clc.2025.11.013

Appears in Collections:: 1. College of Medicine (의과대학) > Dept. of Internal Medicine (내과학교실) > 1. Journal Papers

Yonsei Authors: Cho, Byoung Chul(조병철) https://orcid.org/0000-0002-5562-270X

URI: https://ir.ymlib.yonsei.ac.kr/handle/22282913/211130

사서에게 알리기

Show full item record Find it @ YMLIB

YUHSpace: Response to the Letter to the Editor: "Lazertinib in EGFR-Mutated NSCLC with CNS Metastases: Reinforcing the Role of Third-Generation TKIs through Pooled Analysis

YUHSpace

BROWSE

Browse

Links